Walk onto the loading dock at a major consumer goods factory and you'll see the building blocks of Stepan Company NYSE:SCL everywhere. It makes the surfactants that turn water and oil into soap and the polyols that insulate our homes. For years, this chemical workhorse was a quiet compounder, but it recently hit a wall of rising costs and messy manufacturing. Now, management is aggressively restructuring the business to prove it can be a leaner, more agile specialty player. While the second quarter of 2026 showed a massive jump in earnings, the real story lies in whether this efficiency drive can survive a volatile global supply chain.
Potential Bull Cases
1. Project Catalyst is transforming the cost structure
Management is finally taking a scalpel to the business through an efficiency program called Project Catalyst. The goal is to strip out $100 million in annual costs by 2027, and the results are already arriving. In the second quarter of 2026, the company reported that it's on track to deliver over $60 million in pre-tax savings this year alone. It recently announced a plan to cut about 100 salaried roles and has already shuttered inefficient sites in New Jersey and the United Kingdom. This isn't just about cutting heads; it's about consolidating production into modern, high-volume facilities. By simplifying its footprint, the company is rebuilding the margins that were squeezed during the post-pandemic inflationary spike.
2. Strategic diversification is reducing reliance on big consumer brands
Stepan is successfully pivoting away from its historical dependence on a few giant cleaning companies. It's hunting for growth in what it calls Tier 2 and Tier 3 customers, which typically offer better margins and less pricing pressure. During the first half of 2026, the company logged 500 new customer-product combinations. This push into functional surfactants for the oilfield, agriculture, and construction markets is paying off. Surfactant organic volume grew 7% in the second quarter of 2026, driven by this broad-based expansion. By diversifying its customer base, the company is building a more resilient revenue stream that can withstand a slowdown in any single consumer category.
3. The Pasadena expansion is unlocking specialty capacity
The company's major investment in its Pasadena, Texas facility is now a critical engine for growth. This site focuses on alkoxylation, a process used to create high-value specialty chemicals. Management confirmed that Pasadena has reached roughly 80% utilization and is already delivering supply chain savings. This facility allows the company to bring production in-house that it previously had to outsource, which improves both reliability and profitability. As the site inches toward full capacity in 2027, it provides a structural cost advantage in North America that rivals struggle to match. This physical moat ensures the company can serve the growing demand for specialized industrial applications.
4. Spray foam momentum is driving the polymer segment
Stepan is riding a wave of demand for energy efficiency through its spray foam polyols business. While it started from a modest base, spray foam volume grew threefold year over year in the second quarter of 2026. This initiative is a bright spot in the polymer segment, which saw adjusted EBITDA rise 22% in the same period. As building codes tighten and homeowners look to lower utility bills, the insulation market remains a long-term tailwind. The company has successfully pivoted its rigid polyol technology into this high-growth white space. This move demonstrates management's ability to identify and capture new market share outside of traditional lamination products.
5. Financial discipline and dividend longevity support the floor
Income investors have a reliable partner here, as the company increased its dividend for the 58th consecutive year in 2025. This isn't a business that's playing fast and loose with the balance sheet. Management reduced its net leverage ratio to 2.5 times in the second quarter of 2026, down from 2.9 times a year earlier. It's also moving to monetize non-core assets, including a land sale in Illinois. This combination of a shrinking debt load and a legendary dividend streak provides a solid valuation floor for long-term shareholders. It has the financial flexibility to fund its restructuring while continuing to return cash to those who own the stock.
Potential Bear Cases
1. Volume growth was inflated by customer stockpiling
The strong volume numbers in the second quarter of 2026 come with a significant asterisk. Management estimated that between $5 million to $10 million of EBITDA was likely pulled forward from the second half of the year. Customers were spooked by geopolitical tension in the Middle East and began pre-buying raw materials to avoid potential shortages. This just-in-case buying pattern suggests that the 6% organic volume growth might not be sustainable as inventories normalize. If the third and fourth quarters of 2026 show a sharp deceleration as customers work through that extra stock, the recent stock price gains could evaporate. Investors might be overestimating the organic demand for the company's chemicals.
2. Maintenance turnarounds and raw material volatility remain headwinds
The business is facing specific operational costs that will bite in the coming months. Management flagged $4 million to $5 million in expected costs for the second half of 2026 related to major maintenance turnarounds that only happen every few years. At the same time, the company is battling volatile raw material prices. It had to absorb a $58 million working capital build in the second quarter of 2026 because of higher input costs and increased sales volume. While the company has pass-through contracts, there is always a lag. If oil-related raw materials spike again while maintenance costs are high, the margin recovery story could stall out before it truly finishes.
3. The GAAP loss highlights the high cost of restructuring
While management highlights adjusted figures, the reported GAAP results tell a more painful story. The company reported an $18.5 million net loss for the first half of 2026, entirely driven by a $70.5 million pre-tax restructuring charge. These massive write-offs reflect the high price of fixing the company's aging asset base and shrinking its workforce. There is no guarantee that cutting 100 roles and closing sites won't disrupt customer service or lead to a loss of technical expertise. If the company cuts too deep or the restructuring takes longer than expected, the projected $100 million in savings might never fully hit the bottom line. Execution risk remains the biggest threat to the thesis.
The Moneyball Verdict: 54 out of 100
Our proprietary Moneyball scoring system assigns Stepan an overall Superscore of 54 out of 100, placing it in the Average category. The Superscore is an AI-powered score that evaluates a company's overall strength by combining financial performance, product market position, technological capabilities, leadership quality, and relative valuation. It represents the unification of all our scores into a single score for public companies, with five rating bands: Exceptional (90-100), Strong (75-89), Above Average (60-74), Average (40-59), and Cautious (0-39). This score places the company in the Bottom ~35% of all companies we score, or ahead of roughly 35 out of every 100 companies in our database.
This average score for Stepan signals that its recent earnings jump likely lacks staying power. The rating aligns with the bear case that customers stockpiled raw materials to avoid shortages, which temporarily boosted volume growth. While management pursues $100 million in annual cost savings, the execution risk of a messy restructuring makes this turnaround a high-stakes gamble that the company's current performance doesn't yet justify.